ADC Therapeutics SA (ADCT) Reports Q3 Loss of $0.29/sh

ADC Therapeutics SA (NYSE: ADCT) reported Q3 EPS of ($0.29), versus ($0.62) reported last year.

For earnings history and earnings-related data on ADC Therapeutics SA (ADCT) click here.

You May Also Be Interested In

• ADC Therapeutics (ADCT) PT Lowered to $5 at Guggenheim
• Klarna shares tumble on weak full-year revenue guidance
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print